Behavioral symptoms in patients with breast cancer and survivors

被引：337

作者：

Bower, Julienne E. ^{[1
,2
,3
]}

机构：

[1] Univ Calif Los Angeles, Dept Psychol, Semel Inst, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Semel Inst, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, Semel Inst, Los Angeles, CA 90095 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 05期

关键词：

D O I：

10.1200/JCO.2007.14.3248

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Behavioral symptoms are a common adverse effect of breast cancer diagnosis and treatment and include disturbances in energy, sleep, mood, and cognition. These symptoms cause serious disruption in patients' quality of life and may persist for years after treatment. Patients need accurate information about the occurrence of these adverse effects as well as assistance with symptom management. This review considers four of the most common behavioral sequelae of breast cancer, namely fatigue, sleep disturbance, depression, and cognitive impairment. Research on the prevalence, mechanisms, and treatment of each symptom is described, concluding with recommendations for future studies.

引用

收藏

页码：768 / 777

页数：10

相关论文

共 136 条

[1] The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy [J].

Ahles, TA ;

Saykin, AJ ;

Noll, WW ;

Furstenberg, CT ;

Guerin, S ;

Cole, B ;

Mott, LA .

PSYCHO-ONCOLOGY, 2003, 12 (06) :612-619

[2] Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma [J].

Ahles, TA ;

Saykin, AJ ;

Furstenberg, CT ;

Cole, B ;

Mott, LA ;

Skalla, K ;

Whedon, MB ;

Bivens, S ;

Mitchell, T ;

Greenberg, ER ;

Silberfarb, PM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :485-493

[3] Candidate mechanisms for chemotherapy-induced cognitive changes [J].

Ahles, Tim A. ;

Saykin, Andrew J. .

NATURE REVIEWS CANCER, 2007, 7 (03) :192-201

[4] Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer [J].

Ancoli-Israel, S ;

Liu, LQ ;

Marler, M ;

Parker, BA ;

Jones, V ;

Sadler, GR ;

Dimsdale, J ;

Cohen-Zion, M ;

Fiorentino, L .

SUPPORTIVE CARE IN CANCER, 2006, 14 (03) :201-209

[5] Off-treatment fatigue in breast cancer survivors: A controlled comparison [J].

Andrykowski, MA ;

Curran, SL ;

Lightner, R .

JOURNAL OF BEHAVIORAL MEDICINE, 1998, 21 (01) :1-18

[6] Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer [J].

Andrykowski, MA ;

Schmidt, JE ;

Salsman, JM ;

Beacham, AO ;

Jacobsen, PB .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6613-6622

[7]

[Anonymous], 2000, COCHRANE DB SYST REV

[8] Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer [J].

Antoni, MH ;

Lehman, JM ;

Kilbourn, KM ;

Boyers, AE ;

Culver, JL ;

Alferi, SM ;

Yount, SE ;

McGregor, BA ;

Arena, PL ;

Harris, SD ;

Price, AA ;

Carver, CS .

HEALTH PSYCHOLOGY, 2001, 20 (01) :20-32

[9] Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer [J].

Bardwell, WA ;

Natarajan, L ;

Dimsdale, JE ;

Rock, CL ;

Mortimer, JE ;

Hollenbach, K ;

Pierce, JP .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (16) :2420-2427

[10]

BARDWELL WA, 2007, PSYCHOONCOLOGY 0411

← 1 2 3 4 5 6 7 8 9 10 →